Topic
Y90 Radioembolization
54 Podcasts • 42 Cases • 3 Courses on BackTable
Hear how experienced physicians approach Y90 Radioembolization on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 673 • 08 Sept 2026
Y90 for Liver-Directed Cancer Treatments: The PROACTIF Study
The key to personalizing Y90 may not just be treating the tumor, but understanding how much radiation a patient can tolerate, where to deliver it, and when to safely push the dose. In this episode of the BackTable Podcast, Drs. Tyler Sandow and Ryan Hickey join host Dr. Kavi Krishnasamy to explore strategies for using Y90 in hepatocellular carcinoma and liver metastases. They combine real-world data from a study of nearly 1,000 patients with insights into methodology and the many variables that influence these procedures.
This podcast is supported by an educational grant from Boston Scientific TheraSphere Y-90.
More on Y90 Radioembolization
Loading recent podcasts…
Vascular & IR # 673
Sep 7, 2026
with Dr. Ryan Hickey, Dr. Tyler Sandow, Dr. Venkatesh Krishnasamy
The key to personalizing Y90 may not just be treating the tumor, but understanding how much radiation a patient can...
Vascular & IR # 659
Jun 29, 2026
with Dr. Beau Toskich, Dr. Lingling Du, Dr. Tyler Sandow
How do you safely combine locoregional and systemic therapies to treat hepatocellular carcinoma (HCC) when traditional...
1,300+ listens
Vascular & IR # 655
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone, Dr. Zach Berman
How is Y90 radioembolization rewriting the rules for managing large HCC tumors and creating new curative-intent...
1,700+ listens
Vascular & IR # 651
Jun 1, 2026
with Dr. Kirema Garcia-Reyes, Dr. Zach Berman, Dr. Nima Kokabi
What does it really take to run a high-volume Y90 program that is efficient, scalable, and patient-centered? In this...
1,500+ listens
Tumor Board # 72
Jul 13, 2026
with Dr. Chih-Yi Liao, Dr. Abdul Khan, Dr. Lingling Du
What factors come into play when deciding whether to use liver-directed therapy or systemic therapies for...
Vascular & IR # 657
Jun 22, 2026
with Dr. Beau Toskich, Dr. Juan Gimenez, Dr. Tyler Sandow
What do you do when Y-90 doesn’t deliver the results you expected? In this episode of the 2026 HCC Creator Weekend™,...
1,600+ listens
Vascular & IR # 653
Jun 8, 2026
with Dr. Beau Toskich, Dr. Christopher Malone, Dr. Venkatesh Krishnasamy
How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases?...
1,500+ listens
Vascular & IR # 649
May 26, 2026
with Dr. Nima Kokabi, Dr. Riad Salem, Dr. Zach Berman
Can the right dosimetry approach turn palliative Y90 into a curative therapy? In this episode of the BackTable 2026 HCC...
1,500+ listens
VI Case
Jul 27, 2026
with Dr. Trushar Patel and Dr. Sabeen Dhand
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.